WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Mark Identification

Proof of use for RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

We do not have any records of a proof of use for RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% at this moment.

Click here to add a proof of use for RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Possible trademark infringements of RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Basic Information about RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Serial Number
88132387
Filing Date
26 Sep 2018
Registration Number
5785832
Registration Date
25 Jun 2019
Mark Drawing Code
5

Classifications

Declare the trademark use of RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% on the blockchain with WikiTrademarks.io.

First use of RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% anywhere
RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% was first used on 13 Mar 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%?

1. ALCON INC. Fribourg

2. Aerie Pharmaceuticals, Inc. Bedminster NJ

3. Aerie Pharmaceuticals, Inc. Bedminster NJ

4. Aerie Pharmaceuticals, Inc. Bedminster NJ

Correspondent

Melissa Atherton Alcon Inc.
6201 South Freeway
Fort Worth, TX 76134
United States

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%